A citation-based method for searching scientific literature

Nadine Tung, Nancy U Lin, John Kidd, Brian A Allen, Nanda Singh, Richard J Wenstrup, Anne-Renee Hartman, Eric P Winer, Judy E Garber. J Clin Oncol 2016
Times Cited: 240



Y Miki, J Swensen, D Shattuck-Eidens, P A Futreal, K Harshman, S Tavtigian, Q Liu, C Cochran, L M Bennett, W Ding. Science 1994
Times Cited: 4661




List of shared articles



Times cited

Correlation of MSH2 exonic deletions and protein downregulation with breast cancer biomarkers and outcome in Pakistani women/patients.
Saima Shakil Malik, Sumaira Mubarik, Ayesha Aftab, Ranjha Khan, Nosheen Masood, Muhammad Asif, Razia Bano. Environ Sci Pollut Res Int 2021
2

Molecular Features and Functional Implications of Germline Variants in Triple-Negative Breast Cancer.
Ding Ma, Si-Yu Chen, Jin-Xiao Ren, Yu-Chen Pei, Cong-Wei Jiang, Shen Zhao, Yi Xiao, Xiao-En Xu, Guang-Yu Liu, Xin Hu,[...]. J Natl Cancer Inst 2021
2

Exome sequencing in BRCA1-2 candidate familias: the contribution of other cancer susceptibility genes
Gabriella Doddato, Floriana Valentino, Annarita Giliberti, Filomena Tiziana Papa, Rossella Tita, Lucia Pia Bruno, Sara Resciniti, Chiara Fallerini, Elisa Benetti, Maria Palmieri,[...]. Front Oncol 2021
0

Optimization of prediction methods for risk assessment of pathogenic germline variants in the Japanese population.
Noriko Senda, Nobuko Kawaguchi-Sakita, Masahiro Kawashima, Yukiko Inagaki-Kawata, Kenichi Yoshida, Masahiro Takada, Masako Kataoka, Masae Torii, Tomomi Nishimura, Kosuke Kawaguchi,[...]. Cancer Sci 2021
1


Applications of Next Generation Sequencing to the Analysis of Familial Breast/Ovarian Cancer.
Veronica Zelli, Chiara Compagnoni, Katia Cannita, Roberta Capelli, Carlo Capalbo, Mauro Di Vito Nolfi, Edoardo Alesse, Francesca Zazzeroni, Alessandra Tessitore. High Throughput 2020
3

Should Genetic Testing for Cancer Predisposition Be Standard-of-Care for Women with Invasive Breast Cancer? The Murtha Cancer Center Experience.
Seth K Rummel, Leann A Lovejoy, Clesson E Turner, Craig D Shriver, Rachel E Ellsworth. Cancers (Basel) 2020
4

Germline variants in DNA repair genes associated with hereditary breast and ovarian cancer syndrome: analysis of a 21 gene panel in the Brazilian population.
Simone da Costa E Silva Carvalho, Nathalia Moreno Cury, Danielle Barbosa Brotto, Luiza Ferreira de Araujo, Reginaldo Cruz Alves Rosa, Lorena Alves Texeira, Jessica Rodrigues Plaça, Adriana Aparecida Marques, Kamila Chagas Peronni, Patricia de Cássia Ruy,[...]. BMC Med Genomics 2020
9

Legacy Genetic Testing Results for Cancer Susceptibility: How Common are Conflicting Classifications in a Large Variant Dataset from Multiple Practices?
Kanhua Yin, Yuxi Liu, Basanta Lamichhane, John F Sandbach, Gayle Patel, Gia Compagnoni, Richard H Kanak, Barry Rosen, David P Ondrula, Linda Smith,[...]. Ann Surg Oncol 2020
1

Clinicopathological analysis of early-stage breast cancer patients that meet indications for BRCA1/2 genetic testing.
Hongyu Xiang, Ling Xin, Qian Liu, Hong Zhang, Shuang Zhang, Jingming Ye, Yuanjia Cheng, Ting Li, Yinhua Liu, Ling Xu. Chin J Cancer Res 2020
0

HRness in Breast and Ovarian Cancers.
Elizabeth Santana Dos Santos, François Lallemand, Ambre Petitalot, Sandrine M Caputo, Etienne Rouleau. Int J Mol Sci 2020
5


Genomic Profiling Comparison of Germline BRCA and Non-BRCA Carriers Reveals CCNE1 Amplification as a Risk Factor for Non-BRCA Carriers in Patients With Triple-Negative Breast Cancer.
Xin Huang, Di Shao, Huanwen Wu, Changbin Zhu, Dan Guo, Yidong Zhou, Chang Chen, Yan Lin, Tao Lu, Bin Zhao,[...]. Front Oncol 2020
1

BRCA1/2 pathogenic variants in triple-negative versus luminal-like breast cancers: genotype-phenotype correlation in a cohort of 531 patients.
Lorena Incorvaia, Daniele Fanale, Marco Bono, Valentina Calò, Alessia Fiorino, Chiara Brando, Lidia Rita Corsini, Sofia Cutaia, Daniela Cancelliere, Alessia Pivetti,[...]. Ther Adv Med Oncol 2020
4